Article Information
History
- January 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sharen Lee*,1,
- Jiandong Zhou, MS*,2,
- Carlin Chang, MPhil MRCP3,
- Tong Liu, MD PhD4,
- Dong Chang, MD PhD5,
- Wing Tak Wong, PhD6,
- Keith SK Leung, BSc7,
- Abraham KC Wai, MBChB FRCEM FRCP7,
- Bernard Man Yung Cheung, MBBChir PhD FRCP8,
- Gary Tse, PhD FRCP FFPH#,5 and
- Qingpeng Zhang, PhD#,1
- 1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
- 2School of Data Science, City University of Hong Kong, Hong Kong, China
- 3Division of Neurology, Department of Medicine, The Queen Mary Hospital, Hong Kong, China
- 4Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
- 5Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China
- 6School of Life Sciences, State Key Laboratory of Agrobiotechnology (CUHK), The Chinese University of Hong Kong, Hong Kong, China
- 7Emergency Medicine Unit, The University of Hong Kong, Pokfulam, Hong Kong, China
- 8Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China
- ↵#Correspondence to: Prof. Qingpeng Zhang PhD, School of Data Science, City University of Hong Kong, Hong Kong SAR, China, Email: qingpeng.zhang{at}cityu.edu.hk, Tel: +852 34424727, Prof. Gary Tse, PhD, FRCP, FFPH, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China, Email: garytse86{at}gmail.com
Posted January 05, 2021.
Comparative effects of sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors on new-onset atrial fibrillation and stroke outcomes
